GENEREX BIOTECHNOLOGY CORP | 2013 | FY | 3


Development Stage Company

The accompanying consolidated financial statements have been prepared in accordance with the provisions of FASB ASC Topic 915, “Development Stage Entities.”


us-gaap:DevelopmentStageEnterpriseGeneralDisclosuresTextBlock